JPWO2021177447A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021177447A5 JPWO2021177447A5 JP2022504476A JP2022504476A JPWO2021177447A5 JP WO2021177447 A5 JPWO2021177447 A5 JP WO2021177447A5 JP 2022504476 A JP2022504476 A JP 2022504476A JP 2022504476 A JP2022504476 A JP 2022504476A JP WO2021177447 A5 JPWO2021177447 A5 JP WO2021177447A5
- Authority
- JP
- Japan
- Prior art keywords
- determination
- risk
- absence
- degree
- impairment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000006735 deficit Effects 0.000 claims 24
- 239000000523 sample Substances 0.000 claims 14
- 206010012289 Dementia Diseases 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 11
- 230000003925 brain function Effects 0.000 claims 10
- 206010000117 Abnormal behaviour Diseases 0.000 claims 6
- 208000012219 Autonomic Nervous System disease Diseases 0.000 claims 6
- 206010010904 Convulsion Diseases 0.000 claims 6
- 206010012239 Delusion Diseases 0.000 claims 6
- 208000004547 Hallucinations Diseases 0.000 claims 6
- 206010019233 Headaches Diseases 0.000 claims 6
- 206010044565 Tremor Diseases 0.000 claims 6
- 206010047571 Visual impairment Diseases 0.000 claims 6
- 230000036461 convulsion Effects 0.000 claims 6
- 231100000868 delusion Toxicity 0.000 claims 6
- 230000006866 deterioration Effects 0.000 claims 6
- 230000010483 emotional dysregulation Effects 0.000 claims 6
- 230000014509 gene expression Effects 0.000 claims 6
- 231100000869 headache Toxicity 0.000 claims 6
- 208000011977 language disease Diseases 0.000 claims 6
- 206010027175 memory impairment Diseases 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 230000001953 sensory effect Effects 0.000 claims 6
- 208000029257 vision disease Diseases 0.000 claims 6
- 230000004393 visual impairment Effects 0.000 claims 6
- 230000002255 enzymatic effect Effects 0.000 claims 5
- 208000012661 Dyskinesia Diseases 0.000 claims 4
- 208000016285 Movement disease Diseases 0.000 claims 4
- 208000016354 hearing loss disease Diseases 0.000 claims 4
- 230000001771 impaired effect Effects 0.000 claims 4
- 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 claims 4
- 230000008786 sensory perception of smell Effects 0.000 claims 4
- 208000019116 sleep disease Diseases 0.000 claims 4
- 208000020685 sleep-wake disease Diseases 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 230000037149 energy metabolism Effects 0.000 claims 3
- 210000005087 mononuclear cell Anatomy 0.000 claims 3
- 101100393884 Drosophila melanogaster Glut1 gene Proteins 0.000 claims 2
- 101100230254 Drosophila melanogaster Glut3 gene Proteins 0.000 claims 2
- 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 claims 2
- 101000577126 Homo sapiens Monocarboxylate transporter 4 Proteins 0.000 claims 2
- 101000577129 Homo sapiens Monocarboxylate transporter 5 Proteins 0.000 claims 2
- 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 claims 2
- 102100025273 Monocarboxylate transporter 5 Human genes 0.000 claims 2
- 102100037247 Prolyl hydroxylase EGLN3 Human genes 0.000 claims 2
- 101710170720 Prolyl hydroxylase EGLN3 Proteins 0.000 claims 2
- 101150058068 SLC2A1 gene Proteins 0.000 claims 2
- 101150052594 SLC2A3 gene Proteins 0.000 claims 2
- 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 210000005259 peripheral blood Anatomy 0.000 claims 2
- 239000011886 peripheral blood Substances 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020038991 | 2020-03-06 | ||
| PCT/JP2021/008722 WO2021177447A1 (ja) | 2020-03-06 | 2021-03-05 | 認知症又は脳機能の判定のためのキット及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021177447A1 JPWO2021177447A1 (de) | 2021-09-10 |
| JPWO2021177447A5 true JPWO2021177447A5 (de) | 2022-11-04 |
Family
ID=77614329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504476A Pending JPWO2021177447A1 (de) | 2020-03-06 | 2021-03-05 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2021177447A1 (de) |
| WO (1) | WO2021177447A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024085246A1 (ja) * | 2022-10-21 | 2024-04-25 | 株式会社カネカ | 認知症の罹患の有無の判定のためのキット及び方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1303537B1 (de) * | 2000-07-25 | 2006-09-27 | The Sir Mortimer B. Davis-Jewish General Hospital | Ho-1 suppressor als diagnostischer und prognostischer test für demenz-krankheiten |
| FI20075320A0 (fi) * | 2007-05-07 | 2007-05-07 | Panu Jaakkola | Uusia käyttökelpoisia inhibiittoreita |
-
2021
- 2021-03-05 JP JP2022504476A patent/JPWO2021177447A1/ja active Pending
- 2021-03-05 WO PCT/JP2021/008722 patent/WO2021177447A1/ja active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dos Santos et al. | miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease | |
| Kovarik et al. | Measuring enzyme activity in single cells | |
| Galimberti et al. | Circulating miRNAs as potential biomarkers in Alzheimer's disease | |
| Leidinger et al. | A blood based 12-miRNA signature of Alzheimer disease patients | |
| Piehl et al. | Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment | |
| EP2293069A3 (de) | Verfahren und Zusammensetzungen zum Nachweis von zervikalen Erkrankungen | |
| EP2893039B1 (de) | Marker und verfahren zum nachweis einer posttraumatischen belastungsstörung | |
| CN102869791A (zh) | 用于脆性x染色体综合征(fxs)治疗的预测标记 | |
| Zischka et al. | Differential Analysis of Saccharomyces cerevisiae Mitochondria by Free Flow Electrophoresis* S | |
| CN102762986A (zh) | 阿尔茨海默病的诊断方法 | |
| JPWO2021177447A5 (de) | ||
| Nishitani et al. | Cross-tissue correlations of genome-wide DNA methylation in Japanese live human brain and blood, saliva, and buccal epithelial tissues | |
| Cuevas-González et al. | Expression of microRNAs in periodontal disease: a systematic review | |
| Qin et al. | Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer’s disease | |
| Kamath et al. | A molecular census of midbrain dopaminergic neurons in Parkinson’s disease | |
| Yoshioka et al. | Fluorescence laser microdissection reveals a distinct pattern of gene activation in the mouse hippocampal region | |
| NO20074882L (no) | En fremgangsmate og kit for bestemmelse av tymidin kinaseaktivitet og deres anvendelse | |
| CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
| Alinaghi et al. | Expression analysis and genotyping of dgkz: a gwas-derived risk gene for schizophrenia | |
| Gootjes et al. | Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder | |
| Wiles et al. | Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis | |
| KR101947141B1 (ko) | 산성 스핑고미엘리나제를 이용한 근위축성측삭경화증 진단용 조성물과 진단 마커 검출 방법 | |
| JP6715526B2 (ja) | ストレスバイオマーカー | |
| Kadena et al. | Amyotrophic lateral sclerosis: current status in diagnostic biomarkers | |
| US11497817B2 (en) | Senile dementia treatment formulation and application thereof |